You have 9 free searches left this month | for more free features.

Continuous subcutaneous insulin infusion

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Type2diabetes Trial in Nanning (Henagliflozin, Continuous Subcutaneous Insulin Infusion)

Not yet recruiting
  • Type2diabetes
  • Nanning, Guangxi, China
    First Affiliated Hospital of Guangxi Medical University
Jan 9, 2023

Diabetes, Type 1, Type 1 Diabetes Trial in Escondido (coil-reinforced soft polymer indwelling cannula, soft Teflon indwelling

Completed
  • Diabetes Mellitus, Type 1
  • Type 1 Diabetes
  • coil-reinforced soft polymer indwelling cannula
  • soft Teflon indwelling catheter
  • Escondido, California
    AMCR Institute
Aug 9, 2022

Type 1 Diabetes Trial in Little Rock, Denver, West Des Moines (Insulin aspart SAR341402, Insulin aspart)

Completed
  • Type 1 Diabetes Mellitus
  • Insulin aspart SAR341402
  • Insulin aspart
  • Little Rock, Arkansas
  • +2 more
Apr 21, 2022

Diabetes, Covid19 Trial in Naples (Continuous glucose monitoring (CGM, Dexcom G6))

Terminated
  • Diabetes Mellitus
  • Covid19
  • Continuous glucose monitoring (CGM, Dexcom G6)
  • Naples, Italy
    Federico II University Hospital
Jul 26, 2022

Type 2 Diabetes, Pregnancy in Diabetic Trial in Beijing (Continuous subcutaneous insulin infusion (CSII), Multiple daily insulin

Not yet recruiting
  • Type 2 Diabetes
  • Pregnancy in Diabetic
  • Continuous subcutaneous insulin infusion (CSII)
  • Multiple daily insulin injection (MDI)
  • Beijing, Beijing, China
    Peking University Third Hospital
Nov 28, 2021

Real-world Data for In-silico Evaluation ofNew Software

Completed
  • Diabetes Mellitus, Type 1
  • YpsoPump® insulin pump system
  • Ulm, Germany
  • +1 more
Mar 21, 2022

Diabetes, Type 1 Trial in Toronto (Lyumjev, Humalog)

Recruiting
  • Diabetes Mellitus, Type 1
  • Toronto, Ontario, Canada
    LMC Clinical Research Inc. (Bayview)
Jul 19, 2022

Type 1 Diabetes Trial in New Haven (canagliflozin, basal interruption without canagliflozin)

Completed
  • Type 1 Diabetes
  • New Haven, Connecticut
    Yale University School of Medicine
Sep 17, 2021

Type 1 Diabetes Trial in Loma Linda, Austin (Afrezza (insulin human) Inhalation Powder, insulin degludec, Continuous

Recruiting
  • Type 1 Diabetes
  • Afrezza (insulin human) Inhalation Powder
  • +2 more
  • Loma Linda, California
  • +1 more
Apr 12, 2022

Diabetes, Type 1 Trial in Graz (NNC0471-0119 A, NNC0471-0119 B, NNC0471-0119 D)

Active, not recruiting
  • Diabetes Mellitus, Type 1
  • NNC0471-0119 A
  • +3 more
  • Graz, Austria
    Novo Nordisk Investigational Site
Aug 15, 2022

Type 1 Diabetes, Dermatologic Complication Trial in Herlev (Skin Care Program)

Active, not recruiting
  • Type 1 Diabetes
  • Dermatologic Complication
  • Skin Care Program
  • Herlev, Denmark
    Department of Pediatrics, Herlev Hospital
Feb 11, 2022

Type 1 Diabetes With Hypoglycemia Trial in Caen, Montpellier (Closed-loop insulin infusion driven by continuous glucose

Recruiting
  • Type 1 Diabetes Mellitus With Hypoglycemia
  • Closed-loop insulin infusion driven by continuous glucose monitoring through an algorithm, in free-life conditions
  • Continuous Subcutaneous Insulin Infusion and Continuous Glucose Monitoring
  • Caen, France
  • +1 more
Dec 14, 2021

Diabetes, Type 1 Trial in Mainz (LY900014, Insulin Lispro)

Completed
  • Diabetes Mellitus, Type 1
  • Mainz, Rheinland-Pfalz, Germany
    Profil Mainz GmbH & Co. KG
Jul 30, 2021

Diabetes, Type 1 Trial in Chula Vista (AT247, NovoLog, Fiasp)

Active, not recruiting
  • Diabetes Mellitus, Type 1
  • Chula Vista, California
    ProSciento, Inc
Aug 12, 2022

Accuracy Comparison of Two CGMs in Hospitalized Patients

Active, not recruiting
  • Type 1 Diabetes
  • Type 2 Diabetes
    • La Jolla, California
      UC San Diego Medical Center
    May 16, 2022

    Faster Aspart on Insulin-pump Treated T1DM Patients

    Completed
    • Type 1 Diabetes
    • Insulin Faster Aspart
    • Insulin pump
    • Ciudad Real, Spain
      Obispo Rafael Torija, St.
    Jan 29, 2021

    Diabetes, Type 1, Type 1 Diabetes, Type 1 Diabetes Trial in Melbourne (coil-reinforced soft polymer indwelling cannula)

    Completed
    • Diabetes Mellitus, Type 1
    • +3 more
    • coil-reinforced soft polymer indwelling cannula
    • Melbourne, Australia
      St Vincent's Hospital (Melbourne) Ltd - Fitzroy
    Jan 25, 2021

    Type 1 Diabetes Trial in Santa Barbara (Sansum Closed-Loop Artificial Pancreas, Insulin infusion pump, Continuous Glucose

    Completed
    • Type 1 Diabetes Mellitus
    • Sansum Closed-Loop Artificial Pancreas
    • +4 more
    • Santa Barbara, California
      Sansum Diabetes Research Institute
    Sep 7, 2021

    Type 1 Diabetes Trial in Austin (Fiasp®, Novolog®, 670G hybrid closed loop continuous subcutaneous insulin infusion system)

    Completed
    • Type 1 Diabetes Mellitus
    • Austin, Texas
      Texas Diabetes & Endocrinology
    Sep 9, 2020

    Diabetes, Type 1, Pediatric ALL Trial in Gennevilliers (Monitoring of the patients)

    Recruiting
    • Diabetes Mellitus, Type 1
    • Pediatric ALL
    • Monitoring of the patients
    • Gennevilliers, Ile De France, France
      Isis Diabete Service
    Dec 3, 2020

    Type 1 Diabetes, Pregnancy, High Risk Trial in Worcester (Insulin)

    Recruiting
    • Type 1 Diabetes
    • Pregnancy, High Risk
    • Worcester, Massachusetts
      University of Massachusetts Memorial Medical Center
    May 9, 2022

    Type 1 Diabetes Trial in Spain (Insulin pump)

    Completed
    • Type 1 Diabetes
    • Insulin pump
    • Badalona, Barcelona, Spain
    • +24 more
    Feb 8, 2022

    Type 1 Diabetes Trial in Asheville (Faster Insulin Aspart (Fiasp®))

    Recruiting
    • Type 1 Diabetes Mellitus
    • Faster Insulin Aspart (Fiasp®)
    • Asheville, North Carolina
      Mountain Diabetes and Endocrine Center
    Nov 20, 2020

    Type1 Diabetes Trial in Asheville (Aspart)

    Completed
    • Type1 Diabetes Mellitus
    • Asheville, North Carolina
      Mountain Diabetes and Endocrine Center
    Feb 23, 2021

    Type 1 Diabetes Trial in London (Insulin (circadian), Insulin (flat rate))

    Completed
    • Type 1 Diabetes
    • Insulin (circadian)
    • Insulin (flat rate)
    • London, United Kingdom
      Imperial College Clinical Research Facility
    Mar 19, 2020